We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$58M +$226K +1,203 +0.3%
FP
2
Flagship Pioneering
Massachusetts
$47.2M -$30.1M -160,222 -33%
DM
3
Deerfield Management
New York
$18.7M
Wellington Management Group
4
Wellington Management Group
Massachusetts
$14.7M +$16.4K +87 +0.1%
RG
5
Redmile Group
California
$9.44M -$6.24M -33,184 -34%
BBA
6
Baker Bros. Advisors
New York
$8.46M
BlackRock
7
BlackRock
New York
$8.39M +$475K +2,527 +5%
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.1M +$3.15M +16,738 +44%
AC
9
Aisling Capital
New York
$7.49M
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$4.54M +$5.8M +30,866 New
CAM
11
Cormorant Asset Management
Massachusetts
$4.36M
CC
12
Casdin Capital
New York
$3.77M +$1.39M +7,408 +41%
State Street
13
State Street
Massachusetts
$2.83M +$431K +2,294 +14%
EAM
14
Eventide Asset Management
Massachusetts
$2.21M
Northern Trust
15
Northern Trust
Illinois
$2.01M +$1.47M +7,819 +135%
AIM
16
ARK Investment Management
Florida
$1.98M +$2.2M +11,699 +661%
JP Morgan Chase
17
JP Morgan Chase
New York
$1.93M +$326K +1,733 +16%
AIC
18
AWM Investment Company
New York
$1.84M +$63.6K +338 +3%
CS
19
Candriam SCA
Luxembourg
$1.77M +$2.26M +12,000 New
OM
20
Opaleye Management
Massachusetts
$1.72M +$133K +707 +6%
Millennium Management
21
Millennium Management
New York
$1.67M +$2.13M +11,321 New
EC
22
EcoR1 Capital
California
$1.53M +$1.96M +10,400 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$1.4M +$208K +1,107 +13%
Renaissance Technologies
24
Renaissance Technologies
New York
$1.06M +$850K +4,520 +167%
Citadel Advisors
25
Citadel Advisors
Florida
$975K +$1.25M +6,625 New